---

$1.65

+0.0150 ( +0.92% ) 476.2K

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2023-12-11	Sale	-7501.00	Flowers Lee
2023-11-20	Sale	-15000.00	Rhode Peter
2023-10-23	Sale	-47249.00	Byam Rebecca
2023-09-18	Buy	1800.00	Wong Hing C
2023-09-15	Buy	5000.00	Byam Rebecca
2023-09-15	Buy	500.00	Winer Gary M
2023-09-13	Buy	5000.00	Byam Rebecca
2023-09-12	Buy	1.00	Winer Gary M
2023-09-08	Buy	5000.00	Byam Rebecca
2023-09-07	Buy	5000.00	Byam Rebecca